SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001213900-24-013772
Filing Date
2024-02-14
Accepted
2024-02-14 11:23:05
Documents
2
Group Members
APEX PROSPECT LTD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ea193507-13dwong_ysbio.htm SC 13D 75560
2 PURCHASE AGREEMENT BETWEEN YS BIOPHARMA CO., LTD. AND APEX PROSPECT LIMITED ea193507ex99-1_ysbio.htm EX-99.1 128788
  Complete submission text file 0001213900-24-013772.txt   205898
Mailing Address BUILDING NO. 2, 38 YONGDA ROAD DAXING BIOMEDICAL INDUSTRY PARK DAXING DISTRICT, BEIJING F4 102629
Business Address BUILDING NO. 2, 38 YONGDA ROAD DAXING BIOMEDICAL INDUSTRY PARK DAXING DISTRICT, BEIJING F4 102629 17327133678
YS Biopharma Co., Ltd. (Subject) CIK: 0001946399 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0331
Type: SC 13D | Act: 34 | File No.: 005-94412 | Film No.: 24634355
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 37370 CEDAR BLVD, STE NEWARK CA 94560
Business Address
Wong Fung Ching (Filed by) CIK: 0002011156 (see all company filings)

Type: SC 13D